How to cite item

Proteomics reveals potential non-neuronal cholinergic receptor-effectors in endothelial cells

  
@article{APS6905,
	author = {Yuan-yuan Zhang and Wei Shen and Lian-cheng Zhang and Zhi-yuan Pan and Chao-liang Long and Wen-yu Cui and Yan-fang Zhang and Hai Wang},
	title = {Proteomics reveals potential non-neuronal cholinergic receptor-effectors in endothelial cells},
	journal = {Acta Pharmacologica Sinica},
	volume = {35},
	number = {9},
	year = {2016},
	keywords = {},
	abstract = {Yuan-yuan ZHANG1, Wei SHEN1, Lian-cheng ZHANG1, Zhi-yuan PAN1, Chao-liang LONG1, Wen-yu CUI2, Yan-fang ZHANG1, Hai WANG1, 2, *
1Cardiovascular Drug Research Center, Institute of Health and Environmental Medicine, Academy of Military Medical Sciences, Beijing 100850, China; 2Cardiovascular Drug Research Center, Thadweik Academy of Medicine, Beijing 100039, China
 
Aim: The non-neuronal acetylcholine system (NNAS) in endothelial cells participates in modulating endothelial function, vascular tone, angiogenesis and inflammation, thus plays a critical role in cardiovascular diseases.  In this study, we used a proteomic approach to study potential downstream receptor-effectors of NNAS that were involved in regulating cellular function in endothelial cells.
Methods: Human umbilical vein endothelial cells were incubated in the presence of acetylcholine, oxotremorine, pilocarpine or nicotine at the concentration of 10 μmol/L for 12 h, and the expressed proteins in the cells were separated and identified with two-dimensional electrophoresis (2-DE) and LC-MS.  The protein spots with the largest changes were identified by LC-MS.  Biowork software was used for database search of the peptide mass fingerprints.

Results: Over 1200 polypeptides were reproducibly detected in 2-DE with a pH range of 3–10.  Acetylcholine, oxotremorine, pilocarpine and nicotine treatment caused 16, 9, 8 and 9 protein spots, respectively, expressed differentially.  Four protein spots were identified as destrin, FK506 binding protein 1A (FKBP1A), macrophage migration inhibitory factor (MIF) and profilin-1.  Western blotting analyses showed that treatment of the cells with cholinergic agonists significantly decreased the expression of destrin, FKBP1A and MIF, and increased the expression of profilin-1.

Conclusion: A set of proteins differentially expressed in endothelial cells in response to cholinergic agonists may have important implications for the downstream biological effects of NNAS.

 
Keywords: non-neuronal acetylcholine system; endothelial cell; cholinergic agonist; destrin; FK506 binding protein 1A; macrophage migration inhibitory factor; profilin-1; proteomics; cardiovascular disease
 
The present study was supported by grants from the State Key Research Project of China (AWS11J003) and Tianjing Key Technologies Research and Development Program, China (05ZHGCGX01300).
* To whom correspondence should be addressed. 
E-mail wh9588@sina.com
Received 2013-10-03     Accepted 2014-03-31},
	issn = {1745-7254},	url = {http://www.chinaphar.com/article/view/6905}
}